Product Reports Resources Pricing Login Book a demo

Ruilongnuofu Medical Technology

Health Tech & Medtech · Minhang District, China · Founded 2019

Shanghai-based Ronovo Surgical, operating under the full name Shanghai Ruilongnuofu Medical Technology Co., Ltd., was established in 2019 by co-founders John Ma and Dr. Ying Mao. John Ma, the company's CEO, brings extensive experience from the medical device industry, having held senior positions at Fosun Pharma and Intuitive Surgical. Dr. Ying Mao, the Chief Medical Officer, is a distinguished neurosurgeon and serves as the honorary president of Huashan Hospital, a prominent institution affiliated with Fudan University. This blend of commercial and clinical expertise has shaped the company's strategic direction. Ronovo Surgical has positioned itself in the rapidly expanding market for robotic-assisted surgery, with an initial focus on mainland China. The company addresses the demand for advanced, yet more accessible, minimally invasive surgical options. Its business model centers on the development and sale of a proprietary surgical robotics platform, targeting hospitals and surgical centers. The primary revenue stream is expected from the sale of the Carina™ system and recurring sales of compatible surgical instruments and accessories. The cornerstone of their offering is the Carina™ robotic surgical platform, a modular system designed for versatility in various soft tissue surgeries. This platform is composed of several key components: a primary laparoscopic surgical system, an advanced high-definition imaging system providing functional vision, and a comprehensive set of surgical instruments and accessories. A notable feature is its modularity, which allows for greater flexibility and adaptability in the operating room compared to single-unit systems. The system has successfully completed multi-center clinical trials in specialties such as gynecology and urology, leading to its clearance by China's National Medical Products Administration (NMPA) in early 2024. Keywords: surgical robotics, medtech, minimally invasive surgery, Carina platform, NMPA approved, modular robotics, soft tissue surgery, medical devices, laparoscopy, healthcare technology

Investors

13 investors on Ruilongnuofu Medical Technology's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Lilly Asia Ventures
Series A 10 investors entered at this stage
Notable Capital
Matrix Partners China
Vivo Capital
LRI Jiangyuan Investment
NRL Capital
LongRiver Investments
Yipu Capital
INCE Capital
Wuxi Guolian Venture Capital
King Star Med
Series B+ 2 investors entered at this stage
Johnson & Johnson
Granite Asia

Global footprint

Where Ruilongnuofu Medical Technology has talent and traffic

Workforce by country
5 countries with
team presence
🇨🇳 China84.4%
🇺🇸 United States6.3%
🇨🇭 Switzerland3.1%
🇦🇺 Australia3.1%
🇭🇰 Hong Kong3.1%
5 countries shown

Talent graph

The shape of Ruilongnuofu Medical Technology's talent

Dealroom maps Ruilongnuofu Medical Technology's team person by person — pinpointing the standout operators and scoring them across the six dimensions investors underwrite. The counts and shape below are a public preview; the named individuals and exact scores live in the platform.

4 team members profilednamed & role-tagged by Dealroom
43 employeestotal headcount
2 executives & foundersidentified by name
DimensionScore
AI Talent Score hidden — book a demo
Engineering Score hidden — book a demo
Product Score hidden — book a demo
Go-to-market Score hidden — book a demo
Leadership Score hidden — book a demo
Research Score hidden — book a demo
Book a demo to unlock Ruilongnuofu Medical Technology's exact scores

Source: Dealroom Talent Intelligence. Public profiles show counts and the team's shape only — request a demo for the named individuals, per-person seniority and tenure, and team benchmarks vs peers.

Market sentiment

What the market is saying about Ruilongnuofu Medical Technology

An AI-synthesized read of the highest-engagement posts about Ruilongnuofu Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ruilongnuofu Medical Technology on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.